1. AHRO : Austin Health Research Online
  2. Austin Health research
  3. Journal articles
Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/31805
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDhiman, Kunal-
dc.contributor.authorVillemagne, Victor L-
dc.contributor.authorFowler, Christopher-
dc.contributor.authorBourgeat, Pierrick-
dc.contributor.authorLi, Qiao-Xin-
dc.contributor.authorCollins, Steven-
dc.contributor.authorRowe, Christopher C-
dc.contributor.authorMasters, Colin L-
dc.contributor.authorAmes, David-
dc.contributor.authorBlennow, Kaj-
dc.contributor.authorZetterberg, Henrik-
dc.contributor.authorMartins, Ralph N-
dc.contributor.authorGupta, Veer-
dc.date2022-
dc.date.accessioned2023-01-12T04:43:11Z-
dc.date.available2023-01-12T04:43:11Z-
dc.date.issued2022-12-
dc.identifier.citationAlzheimer's and Dementia 2022en_US
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/31805-
dc.description.abstractFatty acid-binding protein 3 (FABP3) is a biomarker of neuronal membrane disruption, associated with lipid dyshomeostasis-a notable Alzheimer's disease (AD) pathophysiological change. We assessed the association of cerebrospinal fluid (CSF) FABP3 levels with brain amyloidosis and the likelihood/risk of developing amyloidopathy in cognitively healthy individuals.en_US
dc.language.isoeng-
dc.subjectAlzheimer's diseaseen_US
dc.subjectamyloiden_US
dc.subjectearly diagnosisen_US
dc.subjectrisk predictionen_US
dc.subjectscreeningen_US
dc.titleCerebrospinal fluid levels of fatty acid-binding protein 3 are associated with likelihood of amyloidopathy in cognitively healthy individuals.en_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleAlzheimer's and Dementiaen_US
dc.identifier.affiliationIMPACT - The Institute for Mental and Physical Health and Clinical Translation School of Medicine Deakin University Geelong Victoria Australia.en_US
dc.identifier.affiliationDepartment of Psychiatry University of Pittsburgh Pittsburgh Pennsylvania USA.en_US
dc.identifier.affiliationThe Florey Institute of Neuroscience and Mental Healthen_US
dc.identifier.affiliationAustralian e-Health Research Centre CSIRO Health and Biosecurity Brisbane Queensland Australia.en_US
dc.identifier.affiliationDepartment of Medicine The University of Melbourne Melbourne Victoria Australia.en_US
dc.identifier.affiliationMolecular Imaging and Therapyen_US
dc.identifier.affiliationPETen_US
dc.identifier.affiliationNational Ageing Research Institute Parkville Victoria Australia.en_US
dc.identifier.affiliationDepartment of Psychiatry and Neurochemistry Institute of Neuroscience and Physiology the Sahlgrenska Academy at the University of Gothenburg Gothenburg Sweden.en_US
dc.identifier.affiliationSchool of Medical and Health Sciences Edith Cowan University Joondalup Western Australia Australia.en_US
dc.identifier.doi10.1002/dad2.12377en_US
dc.type.contentTexten_US
dc.identifier.pubmedid36479019-
dc.description.volume14-
dc.description.issue1-
dc.description.startpagee12377-
local.name.researcherMasters, Colin L
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.openairetypeJournal Article-
item.grantfulltextnone-
item.cerifentitytypePublications-
item.fulltextNo Fulltext-
item.languageiso639-1en-
crisitem.author.deptMolecular Imaging and Therapy-
crisitem.author.deptMolecular Imaging and Therapy-
crisitem.author.deptThe Florey Institute of Neuroscience and Mental Health-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

58
checked on Oct 3, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.